This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it will report unaudited consolidated financial results for the quarter ended March 31, 2012 after the U.S. financial markets close on Tuesday, May 1, 2012. The announcement will be followed by a conference call and webcast with slides at 4:30 p.m. ET during which management will discuss the company’s financial results, commercial progress and development programs.
To access the conference call via telephone, please dial (877) 412-6083 from the United States or (702) 495-1202 for international access. A telephone replay will be available from approximately 5:30 p.m. ET on May 1, 2012 through midnight May 8, 2012. To access a replay of the conference call, dial (855) 859-2056 from the United States or (404) 537-3406 for international access. The pass code for the live call and the replay is 73223897.
The call will be webcast with slides and accessible through the Investors section of the company’s website at
www.amagpharma.com. The webcast replay will be available from approximately 5:30
p.m. ET on May 1, 2012 through midnight June 1, 2012.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. AMAG manufactures and sells Feraheme
® (ferumoxytol) Injection for intravenous use. For additional company or product information, please visit
Feraheme is a registered trademark of AMAG Pharmaceuticals, Inc.